Advertisement
Screener

agilon health, inc. (AGL) Overview

agilon health, inc. (AGL) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 1.04; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 2.94; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -6.31; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual 0.73; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$7.51$13.42$23.95$42.77$76.36$136.332025-09-292026-09-29$7.51$18.88$47.46$119.25$299.69$753.112021-09-292026-09-29$7.51$20.50$55.92$152.56$416.17$1,135.312021-04-152026-09-29$7.51$20.50$55.92$152.56$416.17$1,135.312021-04-152026-09-29$7.51$20.50$55.92$152.56$416.17$1,135.312021-04-152026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$78.15
Previous close
$79.53
Change
-$1.38
Change (%)
-1.74%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

AGL
+352.73%
S&P 500
(m)

1 year

AGL
+181.10%
S&P 500
(m)

3 years

AGL
-82.43%
S&P 500
(m)

5 years

AGL
-88.08%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 1.04

-6.39-4.01-1.630.743.1231 Mar 2025: estimate (m); actual 0.7331 Mar 2025(m)30 Jun 2025: estimate (m); actual -6.3130 Jun 2025(m)31 Mar 2026: estimate (m); actual 2.9431 Mar 2026(m)30 Jun 2026: estimate (m); actual 1.0430 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)1.04(m)(m)
1 Jan 202631 Mar 2026(m)2.94(m)(m)
1 Apr 202530 Jun 2025(m)-6.31(m)(m)
1 Jan 202531 Mar 2025(m)0.73(m)(m)

(m)

Comparison details
Period startPeriod endingEstimateActualBeat / missReport date

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 1.49B ■ Earnings 0.02B — Profit margin 1.20%

-0.40B-13.0%0.33B-7.2%1.05B-1.4%1.78B4.4%30 Sept 2025: revenue 1.44B; earnings -0.11B; profit margin -7.68%30 Sept 202531 Dec 2025: revenue 1.57B*; earnings -0.19B*; profit margin -12.03%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 1.42B; earnings 0.05B; profit margin 3.44%31 Mar 202630 Jun 2026: revenue 1.49B; earnings 0.02B; profit margin 1.20%30 Jun 2026

31 Dec 2025 ■ Revenue 5.93B ■ Earnings -0.39B — Profit margin -6.60%

-1.17B-7.6%1.50B-6.2%4.17B-4.7%6.83B-3.3%31 Dec 2022: revenue 2.39B; earnings -0.11B; profit margin -4.46%31 Dec 202231 Dec 2023: revenue 4.32B; earnings -0.26B; profit margin -6.08%31 Dec 202331 Dec 2024: revenue 6.06B; earnings -0.26B; profit margin -4.29%31 Dec 202431 Dec 2025: revenue 5.93B; earnings -0.39B; profit margin -6.60%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$78.15(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$78.15High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning AGL

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-232.22M
Profit margin
-3.92%
Return on assets · 12 month
-14.06%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
212.34K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-10.40%*
Total return · month
-15.22%*
Total return · quarter
-32.26%*
Total return · half year
687.94%*
Total return · year to date
352.73%*
Total return · 1 year
181.10%*
Total return · 3 years
-82.43%*
Total return · 5 years
-88.08%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$5.92B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

agilon health, inc. Overview

View more →

(m)

(m)

SEC CIK
1831097
Industry (SIC)
8090 Services-Misc Health & Allied Services, NEC
Country of operation
United States
Business address
440 POLARIS PARKWAY, SUITE 550, WESTERVILLE, Ohio, 43082, United States
Fiscal year end
1231
Phone
562-256-3800

Similar stocks

Stock NameCountryMarket CapPE Ratio
Progyny, Inc. (PGNY)United States$1.994B28.37
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43
Sotera Health Co (SHC)United States$5.271B30.96
DAVITA INC. (DVA)United States$11.147B16.80